
Opinion|Videos|August 27, 2026
Understanding Axatilimab's Mechanism in the Context of Multiple Lines of Therapy
Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, MBA, translates the CSF1R-targeted mechanism into practical pharmacist workflows: distinct toxicity profiles (periorbital edema, hepatic enzyme elevations), drug interaction review for polypharmacy, and how to communicate the mechanistic rationale to patients and community pharmacy teams.
Advertisement
Episodes in this series

Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, MBA, translates the CSF1R-targeted mechanism into practical pharmacist workflows: distinct toxicity profiles (periorbital edema, hepatic enzyme elevations), drug interaction review for polypharmacy, and how to communicate the mechanistic rationale to patients and community pharmacy teams.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis
3
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
4
Yeast-Based Universal Flu Vaccine Fully Protects Mice Against 3 Influenza Strains
5































































































